Myocardial Infarction

Results of the GIANT trial reported

According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention (PCI) may help cardiology teams adjust treatment and improve ischemic outcomes for patients that do not properly metabolize ...

Nov 01, 2013
popularity not rated yet | comments 0

Results of the TRANSLATE-POPS trial presented

According to a new study of heart attack patients treated with percutaneous coronary intervention (PCI), free access to platelet function testing had only a modest impact on anti-clotting drug selection and dosing. Findings ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the HYBRID trial presented

A hybrid approach to treating coronary artery disease that involves a "hybrid procedure" combining a minimally invasive bypass surgery with percutaneous coronary intervention (PCI) was found to be feasible and safe in a clinical ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the FREEDOM sub study reported

According to a recent study of diabetic patients who underwent revascularization for multi-vessel coronary artery disease (CAD), patients treated with insulin experienced more major adverse cardiovascular events after revascularization ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of DUTCH PEERS (TWENTE II) trial reported

Results of the DUTCH PEERS (TWENTE II) clinical trial demonstrate comparable safety and efficacy of two third-generation permanent polymer-based drug-eluting stents with low rates of adverse clinical events and establish ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the ARCTIC-INTERRUPTION trial presented

According to a new study, patients that do not experience a major cardiac event in the first year after receiving drug-eluting stent (DES) may not need to receive prolonged dual antiplatelet therapy (DAPT). Results from the ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the OPTIMIZE trial presented

A new study demonstrates that some patients may not need to receive prolonged anti-clotting therapy after drug-eluting stent (DES) implantation with the Endeavor zotarolimus-eluting stent, and that shortening the duration ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the CHILL-MI trial presented

A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) prior to restoring blood flow is safe and feasible. The findings of ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the SMART-CASE trial presented

A new study shows that a conservative approach to revascularization for patients with intermediate coronary lesions determined by angiographic diameter stenosis is safe and non-inferior to an aggressive approach. Findings ...

Oct 30, 2013
popularity not rated yet | comments 0

Results of the TRYTON trial presented

A clinical trial designed to measure the effectiveness of using a dedicated side branch-covering bare metal stent in true bifurcation coronary lesions found that that the strategy was safe, but the results did not establish ...

Oct 30, 2013
popularity not rated yet | comments 0

Results of the SORT-OUT VI trial presented

A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible ...

Oct 30, 2013
popularity not rated yet | comments 0

Latest Spotlight News

Scientists discover an on/off switch for aging cells

(Medical Xpress)—Scientists at the Salk Institute have discovered an on-and-off "switch" in cells that may hold the key to healthy aging. This switch points to a way to encourage healthy cells to keep dividing ...